Ideal anaesthesia for cataract surgery should give surgeons optimal operative conditions and patients safe and effective anaesthesia. Commonly used anaesthesia for cataract surgery includes retrobulbar, peribulbar, sub-Tenons, subconjunctival, intracameral and topical anaesthesia, or a combination of these techniques. These different anaesthetic techniques all have their roles in modern cataract surgery; however there is a move towards less invasive techniques with minimum complication rates while providing ideal anaesthesia.
Subconjunctival anaesthesia (SCA) has been shown to be effective and safe for a range of ophthalmic surgical procedures, including extracapsular cataract extraction, phacoemulsification, trabeculectomy, phaco-trabeculectomy and contact diode laser cyclophotocoagulation [1] [2] [3] [4] [5] . SCA is usually administered to the supero-temporal or infero-temporal bulbar conjunctiva under direct visualisation of the needle delivering the anaesthesia. The choice of injection site depends on exposure and preference. In a study looking at intraocular penetration of subconjunctival prednisolone in rabbits, significantly decreased prednisolone levels were observed in the cornea and aqueous when the drug was delivered to inferior sites 6 . However, whether the clinical effectiveness of SCA would differ when administered at different sites has not been investigated. This study aims to compare the effectiveness of SCA for routine cataract surgery delivered to the superior and inferior bulbar conjunctiva.
MATERIALS AND METHODS
This study included 103 eyes of 99 consecutive patients undergoing elective cataract extraction and intraocular lens (IOL) implantation between April and November 2001 at the Dubbo Private Hospital, Dubbo, New South Wales, Australia. Ethics approval was obtained from the Macquarie and Far
SuMMARY
This study compared the efficacy of two different injection sites for subconjunctival anaesthesia (SCA) in cataract surgery. One-hundred-and-three eyes of 99 consecutive patients undergoing routine cataract surgery were randomised to receive SCA either to the superior bulbar conjunctiva (n=52) or the inferior bulbar conjunctiva (n=51). Pain experienced during anaesthetic administration and at various stages of the perioperative period was assessed using a simplified scale. Assessment of subconjunctival haemorrhage and chemosis was made by the surgeon. The percentage of patients reporting any pain on administration of superior SCA was 46% compared to 67% with inferior SCA (P=0.036). Moderate to severe pain on SCA injection was experienced by 15% and 18% of those in the superior and inferior SCA groups respectively. The cataract procedure was well tolerated in both groups. There was no difference between the groups for duration of surgery (P=0.25), anaesthetic related complications including chemosis (P=0.28), subconjunctival haemorrhage (P=0.38) or intraoperative complications (P=0.50).
We found that subconjunctival anaesthesia is effective for routine cataract surgery. There was no difference in block efficacy between superiorly and inferiorly delivered SCA. However, superior SCA appeared to be less painful on injection compared to inferiorly delivered SCA.
West Area Health Service Ethics Committee and informed consent was obtained from all patients. Exclusion criteria included any communication problems due to deafness or cognitive impairment.
All subconjunctival blocks were performed by the same anaesthetist (SP). Intravenous sedation (midazolam hydrochloride 1 mg) was administered to all patients before instilling four to six drops of 0.4% benoxinate into both the superior and inferior conjunctival fornices over one to two minutes. Subconjunctival anaesthesia consisted of ropivacaine 8 mg/ml, clonidine 30 μg/ml, hyaluronidase 75 units/ml and adrenaline 5 μg/ml. using an envelope system, patients were randomised to receive 0.8 ml anaesthetic mixture administered 5 mm from the limbus to either the superotemporal (n=52) or the inferotemporal (n=51) bulbar sub-conjunctival space using a 30 gauge needle. A Honnan balloon was then applied at 30 cmH 2 O for approximately 10 minutes to disperse the chemosis. The mean time between SCA injection and commencement of surgery was 23 minutes (SD=11.1).
All cataract surgeries were performed by the same surgeon (HL) through a superior scleral tunnel or a clear corneal incision. Phacoemulsification of the nucleus was followed by irrigation and aspiration of the cortex and intraocular lens implantation in the capsular bag. Subconjunctival gentamicin and betamethasone was given at the end of the procedure.
Patients were asked by a member of the nursing staff, who was blinded to the patient grouping, to score the presence of pain at different stages of the procedure (during SCA injection, incision, phacoemulsification/irrigation and aspiration, subconjunctival gentamicin and betamethasone injection) using a simplified ordinal pain scale: 0=no pain, 1=mild pain, 2=moderate pain, 3=severe pain. Postoperatively, patients were also asked to give an overall score of pain experienced during the procedure. The surgeon assessed the eyes for the presence of noticeable chemosis and subconjunctival haemorrhage at the start of operation.
Other outcome measures included the need for supplemental anaesthesia, duration of surgery and surgical complication rate. Fisher's test was used to compare the rate of surgical complications between superior and inferior SCA groups. All other variables were compared using the two-tailed Student's t-test or Chi-squared tests.
RESuLTS
There were no significant differences between the two groups in age, gender, weight, surgical eye or duration of surgery ( Table 1) . Duration of surgery ranged from 13 to 41 minutes (median=20).
At the time of subconjunctival injection of anaesthetic agent, 46% of patients reported pain in the superior SCA group compared to 67% in the inferior SCA group. The Chi-square test statistic for this difference was P=0.04. For those patients who reported pain on SCA injection, most experienced only mild pain ( Table 2 ). Moderate to severe pain on SCA injection was experienced by 15% and 18% of those in the superior and inferior SCA groups respectively ( Table 2 ). Overall the cataract procedure was very well tolerated in both groups. Only 4% of the superior SCA group and 10% of the inferior SCA group experienced pain during the procedure (P=0.23). Injection of subconjunctival gentamicin and betamethasone was the most painful part of the procedure ( Table 2) . No patients required supplemental anaesthesia.
The rate of these minor complications (the presence of chemosis and subconjunctival haemorrhage) did not differ significantly between the two groups ( Table 3 ). Surgical complications occurred in two patients with superior SCA. Both patients had posterior capsular ruptures with vitreous loss requiring an anterior vitrectomy and a sulcus-fixated posterior chamber intraocular lens. No supplemental anaesthesia was required for these two patients. using Fisher's exact test comparing the surgical complication rates in the two groups, there was no statistical significance (P=0.50). 
DISCuSSION
This study found superiorly administered SCA to be better tolerated on injection than inferiorly administered SCA. Block efficacy and the rate of minor complications were otherwise similar in the two groups.
Previous studies have shown SCA to be effective for cataract surgery 1-3 . Its advantages include direct visualisation of the needle on administration of anaesthesia, small amounts of anaesthetic required 2 , minimal effects on posterior vitreous pressure 2 and pulsatile ocular blood flow 7 , less sedation required and minimal effects on visual acuity 2 . Disadvantages include lack of akinesia and the possibility of globe perforation as reported in one case 8 . Minor disadvantages include chemosis and subconjunctival haemorrhage 4, 5 .
This study found superior SCA to be more comfortable on injection than inferior. Although ultrastructural studies on conjunctival innervation are limited, there have been no documented claims to suggest asymmetrical distribution of sensory nerve fibres in the superior and inferior conjunctiva [9] [10] [11] [12] . In a neurophysiological study comparing superior and inferior bulbar conjunctival sensitivity using a Cochet-Bonnet aesthesiometer, slightly lower average for touch sensitivity was found inferiorly but the difference was not statistically significant 13 .
Despite the observed benefit in superiorly injected SCA, factors influencing safety should be considered when deciding the injection site. These include familiarity of the person giving the block, patient co-operation (for example, patients with strong Bell's phenomenon would favour inferior SCA) and anatomical characteristics such as prominent brow or sunken orbit. Superior SCA should be avoided in trabeculectomy to avoid 'button-holing' potential bleb sites. However, if the factors for either site are identical, then injecting superiorly should be preferred.
Our clinical study supports other clinical studies in demonstrating the effectiveness of SCA in cataract surgery. Both superiorly and inferiorly injected SCA performed equally well in block efficacy. With the exception of four patients reporting mild to moderate pain, all other patients recorded no pain until the subconjunctival injection of gentamicin and betamethasone at the end of the operation. Postoperatively, 92% of patients described the procedure as painless.
The strengths of this study include the randomised nature and the collection of data at different stages of surgery by theatre staff blinded to the patient grouping. In our assessment of pain scores, we used a simple descriptive ordinal scale, rather than a visual analogue pain scalepostoperative questionnaire commonly employed by others 14 . We believe that a simple and understandable four-step ordinal scale recorded intraoperatively provides a more accurate appraisal of surgical pain in our subjects. This is because the amnesic effects of systemic sedative agents, compounded by short-term memory impairment commonly found amongst elderly patients, could lead to unreliable responses to postoperative questionnaires.
The relatively small sample size limited the power of this study in detecting our obtained difference in the proportion of patients experiencing pain on SCA delivery to 58%. This on the other hand makes the finding of our statistically significant result even more compelling.
In this study, one anaesthetist performed all SCAs. Whilst this improved the internal validity of our study, it might limit somewhat the generalisibility of our results to all anaesthetists.
In conclusion, our study confirms the effectiveness of subconjunctival anaesthesia in phacoemulsification surgery. Although injecting at different sites did not alter the effectiveness of the block or its rate of minor complications, injecting at the superior bulbar conjunctiva was less distressing to patients than injecting inferiorly. However, other factors should be considered when choosing an injection site, to ensure safe delivery of the anaesthetic.
